Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - GROSS PROFIT
Gross Profit PRPH - ProPhase Labs, Inc.
16.2 M
LAST VALUE
-29.65%
2 YEAR CAGR
27.71%
5 YEAR CAGR
-0.26%
10 YEAR CAGR